Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of inhaled VR776 (clomipramine hydrochloride) for premature ejaculation
2005-004065-42Phase 2Completed
- Sponsor
- Vectura
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VR776 in premature ejaculation (PE) (2 arms), sponsored by Vectura. Primary endpoints: Intravaginal ejaculatory latency time (IVELT) and Safety and tolerability. Started Oct 2005; status: completed.
02
Drugs
VR776
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2005-004065-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004065-42.